The Martin Delaney Collaboratories:
- BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
- CRISPR for Cure
- Delaney AIDS Research Enterprise to Cure HIV (DARE)
- Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)
- HOPE (HIV Obstruction by Programmed Epigenetics)
- I4C: Immunotherapy for Cure
- Pediatric Adolescent Virus Elimination (PAVE) Martin Delaney Collaboratory
- REACH: Research Enterprise to Advance a Cure for HIV
- RID-HIV (Reversing Immune Dysfunction) for HIV-1 Eradication
- The Collaboratory of AIDS Researchers for Eradication (CARE)
Global Investment in HIV Cure Research and Development
- Global Investment in HIV Cure Research and Development in 2020 – AVAC, International AIDS Society Towards an HIV Cure initiative, September 2020
- Global Investment in HIV Cure Research and Development in 2019 – AVAC, International AIDS Society Towards an HIV Cure initiative, September 2020
- Global Investment in HIV Cure Research and Development in 2018 – AVAC, International AIDS Society (IAS) Towards an HIV Cure initiative, July 2019
- Global Investment in HIV Cure Research and Development in 2017 – AVAC, International AIDS Society (IAS) Towards an HIV Cure initiative, July 2018
- Global Investment in HIV Cure Research and Development in 2016 – AVAC, International AIDS Society (IAS) Towards an HIV Cure initiative, July 2017
- Global Investment in HIV Cure Research and Development in 2015 – AVAC, International AIDS Society (IAS) Towards an HIV Cure initiative, July 2016
- Global Investment in HIV Cure Research and Development in 2014 – AVAC, International AIDS Society (IAS) Towards an HIV Cure initiative, September 2015